Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis
Clinical trial NCT05225805 · COMPLETED
Trial details
- NCT number
- NCT05225805
- Sponsor
- Nabriva Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2022-09-20
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.